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Abbreviations 
Ganglioside nomenclature is in accordance with IUPAC-IUB recommendations (IUPAC-
IUMBMB 1998).  
BSA, bovine serum albumin 
CT-B, cholera toxin-subunit B; 
DRM, Detergent-Resistant Membrane  
GM1, II3Neu5Ac-Gg4Cer, β-Gal-(1-3)-β-GalNAc-(1-4)-[α-Neu5Ac-(2-3)]-β-Gal-(1-4)-β-Glc-Cer; 
GM1 oligosaccharide, II3Neu5Ac-Gg4, OligoGM1, β-Gal-(1-3)-β-GalNAc-(1-4)-[α-Neu5Ac-(2-
3)]-β-Gal-(1-4)-Glc DMEM, Dulbecco’s modified Eagles’ medium; 
FBS, fetal bovine serum; 
HD, high density; 
HPR, horseradish peroxidase; 
HPTLC, high-performance silica gel thin-layer chromatography; 
MAPK, mitogen-activated protein kinase; 
N2a, Neuro2a cells; 
NGF, nerve growth factor; 
PBS, phosphate-buffered saline; 
PNS, postnuclear supernatant; 
PVDF, polyvinylidene difluoride; 
RRID, Research Resource Identifier; 
Trk, neurotrophin tyrosine kinase receptor; 
Tyr490, tyrosine 490. 
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Abstract  
Recently, we highlighted that the ganglioside GM1 promotes neuroblastoma cells differentiation 
by activating the TrkA receptor through the formation of a TrkA-GM1 oligosaccharide complex 
at the cell surface.  
To study the TrkA-GM1 interaction, we synthesized two radioactive GM1 derivatives presenting 
a photoactivable nitrophenylazide group at the end of lipid moiety, 1 or at position 6 of external 
galactose, 2; and a radioactive oligosaccharide portion of GM1 carrying the nitrophenylazide 
group at position 1 of glucose, 3. The three compounds were singly administered to cultured 
neuroblastoma Neuro2a cells under established conditions that allows cell surface interactions. 
After UV activation of photoactivable compounds, the proteins were analyzed by PAGE 
separation. The formation of cross-linked TrkA-GM1 derivatives complexes were identified by 
both radioimaging and immunoblotting. Results indicated that the administration of compounds 
2 and 3, carrying the photoactivable group on the oligosaccharide, led to the formation of a 
radioactive TrkA complex, while the administration of compound 1 did not. This underlines that 
the TrkA-GM1 interaction directly involves the GM1 oligosaccharide, but not the ceramide. 
To better understand how GM1 relates to the TrkA, we isolated plasma membrane lipid rafts. 
As expected, GM1 was found in the rigid detergent resistant fractions, while TrkA was found as 
a detergent soluble fraction component.  
These results suggest that TrkA and GM1 belong to separate membrane domains: probably 
TrkA interacts by ‘flopping’ down its extracellular portion onto the membrane, approaching its 
interplay site to the oligosaccharide portion of GM1.  
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Introduction 
Gangliosides, together with cholesterol, have been described as the driving molecules 
necessary to organize the cellular membranes with heterogeneous lipid distribution and to be 
responsible for the first steps of lipid rafts formation (Sonnino et al. 2006). In the lipid rafts, 
gangliosides can interact with proteins modulating their physical and functional properties 
(Sonnino et al. 2018).  
The ganglioside GM1, marker of plasma membrane lipid rafts, has been described to play key 
functional roles in numerous events (Schengrund 2015; Ledeen and Wu 2015; Aureli et al. 
2016). GM1 is one of the main component of the brain ganglioside pattern and many papers 
have elucidated its role as neurotrophic and neuroprotective molecule in in vitro and in in vivo 
models, comprising humans (Schneider et al 2010, 2013; Ledeen and Wu 2018a, 2018b).  
GM1 exerts its well-known properties through the activation of plasma membrane receptors 
(Ledeend and Wu 2018a, 2018b), nevertheless, understanding whether the activity of a protein 
is determined by the ganglioside influence on membrane organization or by a direct 
ganglioside-protein interaction (Coskun and Simons 2011), is a hard challenge. However, the 
synthesis of tritium labeled and photoactivable gangliosides and their administration to cells in 
culture allows to study the ganglioside-protein interactions (Bisson and Montecucco 1981; 
Sonnino et al. 1989; Mauri et al. 2004). Indeed, after administration to the cells under dark 
conditions, these ganglioside derivatives are taken up by the cells becoming component of the 
plasma membranes and metabolically indistinguishable, from the endogenous compounds 
(Sonnino et al. 1989). Cell illumination produces a very reactive derivative containing nitrene 
capable to react with the molecules in the neighboring environment and forming a covalent 
linkage. Thus, proteins, interacting with the activated ganglioside, form a stable tritium labeled 
complex that can be identified by radioimaging technic after protein separation (Loberto et al. 
2003; Mauri et al. 2004, Prioni et al. 2004; Chiricozzi et al. 2015). A detailed structural analysis 
of the complex allows to identify the involved protein. 
Using this strategy in combination with other biochemical approaches, here, we studied how 
the ganglioside GM1 and the TrkA receptor interact in cultured neuroblastoma cells in vitro. 
This interaction acts as a trigger for the activation of intracellular signaling cascades that 
ultimately produce cell differentiation and cell protection from toxic compounds. In this view 
neurotrophic and neuroprotective properties, long since attributed to GM1 (Mutoh et al. 1995; 
Chiricozzi et al. 2017), find, at least in part, a molecular explanation. In this paper, we present 
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data suggesting that GM1-TrkA interaction occurs between the extracellular moiety of TrkA 
that, probably lying upon the cells, reaches the oligosaccharide head of the GM1 whose 
ceramide portion is inserted in a membrane domain different from the receptor’s.  
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Methods  
 
Materials 
Commercial chemicals were of the highest purity available, common solvents were distilled 
before use and water was doubly distilled in a glass apparatus. 
Cell culture plates and Transfectagro™ reduced serum medium were from Corning (Corning, 
NY, USA). Mouse neuroblastoma Neuro2a (N2a) cells (RRID: CVCL_0470), phosphate-
buffered saline (PBS), HPR-conjugated cholera toxin subunit B (CT-B), o-phenylenediamine 
tablets, H2O2, vibrio cholerae sialidase, 2-propanol, Formic acid, Ponceau S, 3-(4,5,-
dimethylthiazole-2yl)-2,5-diphenyltetrazolium bromide (MTT) and, bovine serum albumin (BSA) 
were from Sigma-Aldrich (St. Louis, MO, USA). Dulbecco’s modified Eagle’s high glucose 
medium (DMEM-HG), Fetal Bovine Serum (FBS), L-Glutamine (L-Glut), Penicillin (10.000 
Units/ml), Streptomycin and 30% acrylamide were from EuroClone (Paignton, UK). Rabbit anti-
TrkA (RRID: AB_10695253), rabbit anti-phospho-TrkA (Tyr490) (RRID: AB_10235585), rabbit 
anti-p44/42 MAPK (ERK1/2) (RRID: AB_390779), rabbit anti-phospho-p44/42 MAPK (p-
ERK1/2) (Thr202/Tyr204) (RRID: AB_2315112) and anti-rabbit IgG (RRID: AB_2099233) 
antibodies were from Cell Signaling Technology (Danvers, MA, USA). Rabbit anti-flotillin (RRID: 
AB_941621) was from Abcam (Cambridge, UK). Mouse anti-calnexin (RRID: AB_397884), goat 
anti-mouse IgG (H+L) antibody (RRID: AB_228307) and Hoechst-33342 fluorescent stain were 
from Thermo Fischer Scientific (Waltham, MA, USA). Chemiluminescent kit for western blot 
was from Cyanagen (Bologna, Italy). Ultima gold was from Perkin Elmer (Waltham, MA, USA). 
4–20% Mini-PROTEAN® TGX™ Precast Protein Gels, Criterion TGX™ Precast Gels, Turbo 
Polyvinylidene difluoride (PVDF) Mini-Midi membrane and DC™ protein assay kit were from 
BioRad (Hercules, CA, USA). High performance thin layer chromatography (HPTLC) and Triton 
X-100 were from Merk Millipore (Frankfurten, Germany). Polyvinylidene difluoride (PVDF) 
membrane was from GE Healthcare Life Sciences (Chigago, IL, USA). 
  
Preparation of ganglioside GM1 and its oligosaccharide. 
GM1 ganglioside was purified from the total ganglioside mixture extracted from fresh pig brains 
collected at the slaughterhouse of the Galbani company (Melzo, Italy), according to the 
procedure developed previously (Tettamanti et al. 1973). The ganglioside mixture, 5 g as sialic 
acid, was dissolved in prewarmed (36°C) 500 mL of 0.05 M sodium acetate, 1 mM CaCl2 buffer, 
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pH 5.5. Vibrio cholerae sialidase (1 unit) was added to the solution every 12 h (Acquotti et al. 
1994). Incubation at 36°C and under magnetic stirring was maintained for two days, and the 
solution dialyzed at 23°C for 4 days against 10 L of water changed 5 times a day. The sialidase 
treated ganglioside mixture was subjected to 150 cm x 2 cm silica gel 100 column 
chromatography equilibrated and eluted with chloroform-methanol-water, 60:35:5 by vol. The 
fractions containing GM1, identified by TLC, were pooled, dried and submitted to a further 
column chromatographic purification using the above experimental conditions. Fractions 
containing pure GM1 were collected and dried. The residue was dissolved in chloroform-
methanol (2:1 v/v) and precipitated by adding 4 volumes of cold acetone. After centrifugation 
(15.000 x g) the GM1 pellet was separated from the acetone, dried, dissolved in 50 mL of 
deionized water and lyophilized giving 1350 mg of white powder which was stored at -20°C. 
GM1 containing tritium at position 6 of external galactose was prepared by enzymatic oxidation 
with galactose oxidase followed by reduction with sodium boro[3H]hydride (Sonnino et al. 1996). 
The oligosaccharides II3Neu5Ac-Gg4 and II3Neu5Ac-[3H]Gg4 were prepared by ozonolysis 
followed by alkaline degradation (Wiegandt and Bucking 1970), from GM1 and [3H]GM1 
respectively. Altogether, NMR, MS, HPTLC and autoradiographic analyses showed a 
homogeneity over 99% for all the prepared gangliosides and oligosaccharides (data not 
shown). 
Tritium labeled and photoactivable GM1, 1 and 2, and GM1 oligosaccharide, 3, (Fig. 1), were 
prepared according to the scheme reported in supplementary materials (Figs. S1, S2 and S3) 
as previously reported respectively in Mauri et al. 2004, Prioni et al. 2004 and Chiricozzi et al. 
2017. 
Photoactivable GM1 oligosaccharide, 3, [6-3H-IVGal-]OligoGM1-N3, bearing the photosensitive 
group on the glucose, as well as photoactivable GM1 1, [6-3H-IVGal-]GM1-N3, bearing the 
photoactivable group on the fatty acid moiety, were prepared from galactose-tritiated GM1. 
Photoactivable GM1 2, [3-3H-Sph-]GM1-N3 bearing the photoactivable group linked at position 
6 of external galactose was prepared from GM1 tritiated at position 3 of the sphingosine. 
Briefly, to prepare photoactivable OligoGM1, 52 µmoles of II3Neu5Ac-[3H]Gg4 (0.5 Ci/mmol) 
were dissolved in 33% ammonia and treated with 1 mg of ammonium hydrogen carbonate. The 
reaction was maintained under stirring for 48 h at 40°C. The solution was then immediately 
freeze-dried (Lubineau et al. 1995). The same approach was followed for the preparation of 
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photosensitive GM1 on the external galactose. In this case, however, tritiated GM1 was firstly 
subjected to enzymatic oxidation at position 6 of the last galactose.  
To insert the photoactivable group on fatty acid residue, galactose-tritiated GM1 was firstly 
submitted to alkaline hydrolysis to remove the stearic acid residue, followed by acid coupling 
with 12-aminododecanoic acid. The reaction occurred adding 350 μmol of 12-aminododecanoic 
acid, dissolved in 2.5 mL of dry tetrahydrofuran (12,5%, v/v) to 1.5 mL of dimthylformamide 
(7,5%) containing 80 μmoles of deacyl-GM1, 1 mL of Triton X-100 (5%, v/v) and 15 mL of dry 
triethylamine (75%, v/v). The reaction mixture was maintained under continuous magnetic 
stirring for 24 h at 23°C. The mixture was evaporated under vacuum to 1 mL, and 25 mL of 
ethyl acetate was added (Sonnino et al. 1989).  
Finally, all the amino-derivatives were properly treated to insert the chosen photoactivable 
group. In particular, the azide labeling procedure started with the dissolution of the crude amino-
derivatives obtained by previous reaction in 0.5 mL of dry dimethylformamide. Then 1 mg of 2-
nitro-4-fluoro-phenylazide and 1 µL of tributylamine in 25 µL of dry DMSO were added under 
dark conditions. Maintaining dark conditions for the entire process, the reaction mixture was 
stirred overnight at 80°C. After solvent evaporation, the photoactivable compounds were 
purified by flash chromatography using chloroform/methanol/2-propanol/water 60 : 35 : 5 : 5 
v/v/v/v as eluent for GM1 oligosaccharide (Mauri et al. 2004) and chloroform/methanol/water 
60 : 35 : 8 v/v/v for GM1 (Sonnino et al. 1989). All the derivates were solubilized in methanol 
and stored at 4°C.  
HPTLC analyses were performed using the solvent system chloroform/methanol/0.2% CaCl2, 
60:35:8 by vol. Bound sialic acid was determined by the resorcinol-HCl method (Svennerholm 
1957; Takki-Luukkainen and Miettinen 1959), pure Neu5Ac being used as the reference 
standard. 
 
Cell cultures 
N2a cells were cultured and propagated as monolayer in DMEM-High Glucose medium 
supplemented with 10% heat inactivated FBS, 1% L-Glutamine and 1% penicillin/streptomycin, 
at 37°C in a humidified atmosphere of 95% air / 5% CO2. Cells were sub-cultured to a fresh 
culture when growth reached the 80-90% confluence (i.e. every 3-4 days).  
 
Cell authentication  
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N2a cells are not listed as a commonly misidentified cell line by the International Cell Line 
Authentication Committee. N2a cells were bought from Sigma-Aldrich to which they were 
supplied by European Collection of Authenticated Cell Cultures (ECACC) (Catalogue No. 
89121404; Lot No. 13K010, passage +9). N2a were used from passage +10 to passage +15 to 
conduct experiments reported in the present manuscript.  
To verify the authentication of employed N2a cells we performed the following tests at the 
beginning and end of single experimental work.  
Morphology check by microscope  
To identify the state of cells, we checked cellular morphology by phase contrast microscopy 
(Olympus BX50 microscope; Olympus, Tokyo, Japan). Morphological outcomes of N2a cells 
confirmed the expected neuronal/ameboid-like morphology (data not shown). 
Growth curve analysis  
Cell proliferation was evaluated according to MTT method (Mosmann 1983, Chiaretti et al. 
2016). Briefly, 2.4 mM MTT (4 mg/ml in PBS) were added to each well and plates were re-
incubated for 4 h at 37°C. Medium was carefully removed and replaced with 2-propanol: formic 
acid, 95:5 (v/v). Plates were gently agitated prior to read the absorbance at 570 nm with a 
microplate spectrophotometer (Wallac 1420 VICTOR2TM, Perkin Elmer). The growth profile 
showed a normal growth rate (data not shown). 
Mycoplasma detection  
Mycoplasma infection was evaluated by fluorescent Hoechst staining (Aureli et al. 2012), a 
fluorescent dye that binds specifically to DNA and that reveals the presence of mycoplasma 
infections as extracellular particulate or filamentous fluorescence at 400X magnification using 
NikonEclipse Ni upright microscope. The mycoplasma test has always given negative results 
(data not shown).  
 
Ganglioside and oligosaccharide treatments 
N2a cells were plated at 5 x 103/cm2 and incubated for 24 h to allow cells attachment and 
recovery in complete medium before all treatments.  
To induce neurodifferentiation, growth medium was removed and cells were pre-incubated in 
pre-warmed (37°C) Transfectagro™ medium containing 2% FBS, 1% L-glutamine, 1% 
penicillin/streptomycin, for 30 min at 37°C. Sequentially cells were incubated at 37°C in the 
presence of 50 μM gangliosides or oligosaccharides (Chiricozzi et al. 2017) 
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Fate of GM1 oligosaccharide photoactivable derivative to N2a cells 
Fate of GM1 oligosaccharide photoactivable derivative to N2a cells was determined using 
tritium-labeled [6-3H-IVGal-]OligoGM1-N3. After the cell administration with 50 μM [6-3H-IVGal-
]OligoGM1-N3 for different times (3 and 24 h), the medium was removed and the following 
treatments were performed sequentially: (i) cells were washed five times with 10% FBS-
medium to remove the amount of [6-3H-IVGal-]OligoGM1-N3 weakly associated to the cells – 
serum removable fraction; (ii) cells were treated with 0.1% trypsin solution to evaluate the [6-
3H-IVGal-]OligoGM1-N3 strongly linked to extracellular domain of plasma membrane proteins – 
trypsin removable fraction; (iii) cells were lysed in order to evaluate the quantity of [6-3H-IVGal-
]OligoGM1-N3 internalized - trypsin stable fraction. The radioactivity associated to each fraction 
was determined by liquid scintillation counting using a beta-counter system (PerkinElmer). The 
entire procedure was performed in dark condition under red safelight omitting cell UV 
illumination to induce photo-activation. The procedure was established previously to determine 
the fate of gangliosides administered to cells in culture (Chigorno et al. 1985; Chiricozzi et al. 
2017). 
 
Photolabeling experiments 
To study the interplay between GM1 and TrkA, cells were incubated with 50 µM of compound 
1, 2 or 3 (Fig. 1), for 3 h at 37°C in the dark. After incubation, medium was removed and cells 
were illuminated for 40 min under UV light (λ= 360 nm) on ice to induce photo-activation. All 
the procedures before exposure to UV light were performed under red safelight. The cells were 
lysed and subjected to 4-20% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) and transferred on PVDF membrane. Digital autoradiography of the PVDF membrane 
was performed with Beta-Imager 2000 (Biospace, Paris).The same PVDF membrane was then 
incubated with anti-TrkA antibody following a blocking step in 5% non-fat milk in TBS-Tween 
0,1% (Sonnino et al. 1989; Chigorno et al. 1990; Sonnino et al. 1992; Loberto et al. 2003; 
Chiricozzi et al. 2015, Chiricozzi et al. 2017).  
 
Isolation of Detergent-Resistant Membrane (DRM) Fractions 
To verify the presence of TrkA in the plasma membrane microdomain, N2a cells were incubated 
in the absence (control) or in the presence of 50 µM GM1 or 50 µM OligoGM1 for 3 h at 37°C. 
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DRM were prepared by ultracentrifugation on discontinuous sucrose gradient of cells subjected 
to homogenization with 1% Triton X-100, as previously described (Chiricozzi et al. 2015; 
Schiumarini et al. 2017). Briefly, cells were mechanically harvested in PBS 1X and centrifuged 
at 270 ×g for 10 min at 4°C. Cell pellet was lysed in 1.2 mL of 1% Triton X-100 in TNEV buffer 
(10mM TrisHCl 10, 150 mM NaCl, 5 mM EDTA pH 7.5) in the presence of 1 mM Na3VO4, 1 mM 
PMSF, and 75 mU/ml aprotinin and homogenized for 11 folds with tight Dounce. Cell lysate (2 
mg of cell protein/mL) was centrifuged for 5 min at 1300 ×g at 4°C to remove nuclei and cellular 
debris and obtain a postnuclear supernatant (PNS). A volume of 1 ml of PNS was mixed with 
an equal volume of 85% sucrose (w/v) in TNEV buffer containing 1 mM Na3VO4, placed at the 
bottom of a discontinuous sucrose gradient (30-5%), and centrifuged for 17 h at 200,000 ×g at 
4°C. After ultracentrifugation, 12 fractions were collected starting from the top of the tube. The 
light-scattering band, corresponding to the detergent-resistant membrane (DRM) fraction, was 
located at the interface between 5% and 30% sucrose corresponding to fraction 5 or 6. The 
entire procedure was performed at 0–4° C on ice immersion. Equal amounts from each fraction 
were used for protein and lipid analysis.  
 
Protein analysis 
Equal amounts of proteins derived from photolabeled cells, from gradient fractions or from 
GM1/OligoGM1 treated/untreated cells were denatured, separated on 4–20% polyacrylamide 
gels, and transferred to PVDF membranes using the Trans-Blot® Turbo™ Transfer System 
(Bio-Rad). The presence of TrkA, Flotillin or Calnexin was determined by specific primary 
antibody, followed by reaction with secondary HRP-conjugated antibody.  
For the time course analysis of TrkA-ERK1/2 activation, proteins derived from GM1/OligoGM1- 
treated and untreated cells were denatured, separated on 7.5% polyacrylamide gels, and 
transferred to PVDF membranes. The presence of TrkA, p-TrkA, ERK1/2 and p-ERK1/2 was 
determined by specific primary antibodies, followed by reaction with secondary HRP-
conjugated antibodies.  
The data acquisition and analysis were performed using Alliance Uvitec (Cleaver Scientific, 
United Kingdom). 
 
Protein determination  
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Protein concentration of samples was assessed using a DC™ protein assay kit according to 
manufacturer’s instructions, using bovine serum albumin as standard. 
 
Lipid extraction and GM1 detection 
Sucrose fractions were dialyzed, lyophilized and subjected to lipid extraction. Total lipids were 
extracted with chloroform/methanol/water, 20 : 10 : 1 by vol, followed by a second extraction 
with chloroform/methanol, 2 : 1 by vol (Prinetti et al. 2011; Chiricozzi et al. 2014; Samarani et 
al. 2018). Lipids were separated by Thin Layer Chromatography (TLC), then GM1 ganglioside 
was specifically detected with HPR-conjugated cholera toxin B (CT-B) staining directly on TLC 
(Wu and Ledeen 1988, Valaperta et al. 2007, Chiricozzi et al. 2018a). Briefly, sample were 
spotted on a silica gel 60 HPTLC plate and developed in chloroform/methanol/0.2% aqueous 
CaCl2, 50: 42 :11 by vol. Following solvent evaporation, the plate was treated for 30 s with a 
solution of 0,2% (v/v) polyisobutylmethacrilate in hexane for three times and air dried for 1 h. 
After 1 h of pre-incubation at 23°C in PBS containing 3% BSA (w/v), the plate was overlaid with 
CT-B subunit-HPR conjugated (40 ng) in 1% BSA (w/v) at 23°C for 1 h. After washing 3 times 
with PBS, plates were developed with o-phenylendiamine (1 tablet in 1.8 mL of citrate-
phosphate buffer 0.05 M (pH 5) and 17 μL of H2O2). 
 
Morphological analysis 
Cultured cells, treated or not with GM1 or OligoGM1 were observed by phase contrast 
microscopy (200x magnification, Olympus BX50 microscope; Olympus, Tokyo, Japan). At least 
10 fields from each well were photographed for each experiment. 
 
Statistical analysis 
Data are expressed as mean ± SEM. The normality of data was not assessed because the 
number of the samples was too small. Thus, data were analyzed for significance by Mann 
Whitney test. The analysis was performed with Prism software (GraphPad Software, Inc. La 
Jolla, CA, USA). 
 
Other analytical methods 
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NMR spectra were recorded with a Bruker AVANCE-500 spectrometer at a sample temperature 
of 298 K. NMR spectra were recorded in CDCl3 or CD3OD and calibrate using the TMS signal 
as internal reference. 
Mass spectrometric analysis were performed in positive or negative ESI-MS. MS spectra were 
recorded on a Thermo Quest Finningan LCQTM DECA ion trap mass spectrometer, equipped 
with a Finnigan ESI interface; data were processed by Finnigan Xcalibur software system. 
All reactions were monitored by TLC on silica gel 60 plates (Merck).  
Radioactivity associated with cells and trypsin and serum labile cell fractions was determined 
by liquid scintillation counting. Digital autoradiography of the PVDF membranes was performed 
with a Beta-Imager 2000 (Biospace, Paris).  
 
No randomization or blinding procedures were performed for our experiments.  
Institutional approval was not needed.  
The study was not-preregistered. 
No sample calculation was performed to predetermine the sample size.  
No test for outliers was conducted because all the data obtained were included in the analysis.  
Custom-made materials will be shared upon reasonable request. 
The n number (n=) in the figure legend indicates the number of independent cell culture 
preparations.  
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Results 
 
Time course of the TrkA-ERK1/2 signaling pathway 
The ability of GM1 and its oligosaccharide, OligoGM1, to activate the TrkA-MAPK pathway after 
24-48 h from their exogenous administration, has been reported (Chiricozzi et al. 2017). 
In order to examine the time course of TrkA-ERK1/2 pathway activation induced by GM1 and 
its oligosaccharide, OligoGM1, the phosphorylation levels of TrkA on Tyr490 and of Erk1/2 on 
Thr202/Tyr204 were followed by immunoblotting analysis.  
As shown in Figure 2, GM1 and OligoGM1 caused a rapid elevation of TrkA phosphorylation, 
detectable right after 30 min and significantly maintained for over the 12 h time course. The 
enhancement in ERK1/2 phosphorylation appeared successively, getting significant after 6 h 
from GM1 and OligoGM1 administration (Fig. 2). The results revealed that, following GM1 and 
OligoGM1 treatment, TrkA Tyr490 phosphorylation increased two-fold in 3 h and Erk1/2 
phosphorylation doubles in 6 h, respect to control untreated cells. Both proteins remained 
hyperphosphorylated for the following 24-48 h (Chiricozzi et al. 2017). In parallel, the 
morphological analysis revealed the acquisition of neuron-like morphology of N2a cells 
(sprouting and elongation of neuritis), confirming that the differentiation processes occurred 
(Fig. 2).  
 
Photolabeling experiments 
The ability of GM1 to directly, tightly and specifically associate with TrkA has been 
demonstrated by Mutoh (Mutoh et al. 1995). To characterize in detail which molecular part of 
GM1 is delegated to the interaction with TrkA receptor, we performed photolabeling 
experiments using the tritium labeled gangliosides 1 and 2 with the photoactivable group carried 
by ceramide and external galactose, respectively, and the tritium labeled GM1 oligosaccharide 
3 with the photoactivable group carried by glucose. Figure 1 reports the three structures 
generated in our laboratory according to the scheme described in Figs. S1, S2 and S3 as 
indicated in supplementary section (Sonnino et al. 1989; Mauri et al 2004; Prioni et al. 2004; 
Chiricozzi et al. 2017). 
Previous information reported that under controlled conditions, ganglioside derivatives 1 and 2 
administered to the cells are taken up by the cells and incorporated into the cell plasma 
membrane with metabolic results that are indistinguishable from the endogenous GM1 
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ganglioside (Mauri et al 2004, Prioni et al. 2004; Sonnino et al. 1989). Differently, the GM1 
oligosaccharide derivative 3 does not enter into the cells neither inserts in the plasma 
membrane, but interacts in a non- covalent manner with the cell surface as shown in Figure S4 
(Chiricozzi et al. 2017). 
N2a cells were incubated for 3 h at 37 °C with the photosensitive derivatives, under dark 
conditions, and illuminated by UV-light for 40 min at 4°C to induce covalent cross-linking 
between radioactive derivatives and neighboring cell components. Under UV irradiation. the 
azide of the nitrophenyl-azide group becomes a nitrene, that immediately generates covalent 
bonds with adjacent molecules, due to its high reactivity. In this way, proteins interacting with 
the azide bearing radioactive molecules becomes radiolabeled as well (Sonnino et al. 1989). 
Cell proteins were separated by SDS-PAGE, transferred on a PVDF membrane and visualized 
by digital autoradiography as well as by colorimetric assay. Among the entire N2a protein 
pattern (Fig. S5, line 2), only few radioactive bands were detected on PVDF (Fig. S5, line 1). 
The radioactive tracks identify proteins cross-linked with the photoactivated compound, 
therefore proteins that were in close proximity to photoactivable compound before illumination. 
A radioactive protein pattern was identified using both the ganglioside derivatives 1 and 2 
incorporated into the plasma membranes, as well as using the oligosaccharide derivative 3 that 
was not taken up by the cells. In the three experimental models, the difference between the 
protein and the radioactive protein patterns suggests specific protein-ganglioside and protein-
oligosaccharide interactions (Fig. 3).  
Following the autoradiography, the PVDF membranes were immunostained with anti-TrkA 
antibody. The band corresponding to TrkA signal was found to perfectly overlap a radiolabeled 
band at 140 kDa in cells treated with ganglioside derivative 2, carrying the photoactivable group 
on the external galactose and with the oligosaccharide derivative 3, carrying the photoactivable 
group on the glucose (Fig. 3B-C). No correspondence of TrkA signal with radioactive track was 
found when cells were treated with the GM1 derivative 1, carrying the photoactivable group at 
the end of ceramide (Fig. 3A). 
These results suggest that the TrkA-GM1 complex formed through the interaction between the 
TrkA and the oligosaccharide head of the ganglioside GM1, does not involve the presence of 
ceramide portion in close proximity to the receptor. 
 
Membrane lipid domains characterization 
16 
 
The above results support the hypothesis that TrkA and GM1 inserted into the external lipid 
layer of the plasma membrane, are near enough to interact. Contrary to this possibility, there 
are previous information reporting that the ganglioside GM1 localizes in lipid membrane 
domains, the lipid rafts, and that the TrkA receptor places in the fluid membrane environment 
separated from the lipid rafts (Limpert et al. 2007; Ichikawa et al. 2009; Pryor et al. 2012). 
To better understand this point, after treating N2a cells with GM1 ganglioside or with its 
oligosaccharide, lipid rafts were isolated as the detergent-resistant membrane (DRM), 
according to the procedure described in Methods section.  
Lipids were extracted from each fraction, separated by HPTLC and ganglioside GM1 content 
was revealed by TLC-staining with cholera toxin B subunit (CT-B). In all experimental conditions 
(control cells, GM1-treated cells and GM1 oligosaccharide treated cells) GM1 was found in the 
rigid membrane fractions non-solubilized by the detergent (Fig. 4), which is in total agreement 
with the large information available from the literature (Limpert et al. 2007; Ichikawa et al. 2009; 
Pryor et al. 2012). Differently, in any experimental condition, western blotting analysis revealed 
that TrkA was present in the fluid membrane fraction, solubilized by the detergent (Fig. 4). This 
result supports the photoactivable data and highlights that TrkA and GM1 interacts through the 
oligosaccharide chain in the extracellular environment since GM1 and TrkA belong to separate 
membrane portions.  
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Discussion 
 
Gangliosides are amphiphilic compounds with a good balance between the hydrophilic head, 
represented by the oligosaccharide group, and the highly hydrophobic ceramide (Sandhoff et 
al. 2018). The gangliosides oligosaccharide protrudes into the extracellular environment where 
may interact with the extracellular part of the other membrane components, while the ceramide 
is inserted into the lipid membrane layer serving to anchor the total structure in restricted 
membrane areas known as “lipid rafts” (Sonnino et al. 2006, 2017). It is believed that in the lipid 
rafts, sphingolipids modulate the functional features of several membrane proteins (Coskun 
and Simons 2011). Since gangliosides are highly segregated together with cholesterol in liquid-
ordered lipid domains with locally reduced fluidity (Sonnino et al. 2006, Grassi et al. 2018), it is 
suggested that proteins co-segregating with them display a restricted lateral motility. Such 
microenvironment, characterized by stable interactions results instrumental for ganglioside-
dependent protein specific fine modulation. In addition, glycosphingolipid oligosaccharide 
chains are recognized by soluble ligands, such as that of GM1 by cholera toxin (Svennerholm 
1976) and that of neutral glycolipid Gb3Cer by verotoxin (Lingwood 1999; Chiricozzi et al. 
2018b). Moreover, the GD1a and GT1b oligosaccharide chains interact with the myelin-
associated glycoprotein (Schnaar and Lopez 2009) belonging to the interfacing membrane of 
adjacent cells.  
However, in most cases the molecular mechanisms underlying the modulatory effect of 
gangliosides on the protein functions remains obscure.  
The increase of GM1 at the cell surface, obtained with any experimental strategy, promotes 
neurite production and cell differentiation in neuroblastoma cells (Facci et al. 1984; Farooqui et 
al. 1997; Mutoh et al. 2002; Rodriguez et al. 2001; Da Silva et al. 2005; Valaperta et al. 2007; 
Schneider et al. 2015). Experimental results indicate that this is due to TrkA activation by GM1 
(Rabin and Mocchetti 1995; Ferrari et al. 1995; Farooqui et al. 1997; Mutoh et al. 1995, 2002; 
Rabin et al. 2002; Duchemin et al. 2002) and more in detail, due to the interaction between 
TrkA and the head group of GM1, its oligosaccharide (Chiricozzi et al. 2017). In PC12 cells, 
where GM1 in the absence of NGF is not able to induce neurodifferentiation (Ferrari et al. 1983), 
the GM1 association with TrkA strongly improves neurite outgrowth and neurofilament protein 
expression elicited by a low dose of NGF, inducing a 3 fold increase in NGF-induced Trk 
autophosphorylation (Mutoh et al. 1995). Important to note, that NGF, even if not synthetized 
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by N2a cells (Leon et al. 1994) is present in our experimental condition since the culture medium 
used contains serum (Chiricozzi et al. 2017). Molecular dynamics calculations suggest that 
hydrogen bonds and ionic interaction between sugars and TrkA-NGF amino acids stabilize a 
TrkA-NGF-GM1 complex (Chiricozzi et al. 2017). This means that the ganglioside 
oligosaccharide is not more distant than 4-5 Å from the receptor, during the interaction. GM1 
belongs to a rigid membrane environment and is considered one of the marker of lipid rafts. On 
the other hand, it is reported that TrkA is associated to a membrane fluid environment 
displaying, at least under specific conditions, some dynamics (Limpert et al. 2007; Ichikawa et 
al. 2009; Pryor et al. 2012). Here, we fractionated the total cell homogenate prepared from cells 
treated, or not treated, with ganglioside GM1 or its oligosaccharide and, in agreement with the 
available information, GM1 was found in the rigid membrane fractions while TrkA was found in 
the fluid fraction solubilized by the detergent (Fig. 4).  
From our previous results, we know that the ceramide portion of GM1 is not necessary for the 
TrkA activation (Chiricozzi et al. 2017), and the results on the membrane topology of TrkA and 
GM1 suggest that GM1 ceramide is not strictly part of the environment of TrkA. To better 
understand how the TrkA-GM1 interaction occurs, we synthesized three tritium labeled 
photoactivable compounds (Fig. 1): 1) GM1 carrying the photoactivable group linked at the end 
of the acyl moiety, 2) GM1 carrying the photoactivable group linked to the external galactose, 
and, 3) the free GM1 oligosaccharide with the photoactivable group linked to glucose. 
The three compounds were added to the cell medium. We know that, under established and 
here used conditions, the GM1 derivative administered to the cells is taken up by the cells 
becoming component of the cell plasma membranes and metabolically indistinguishable from 
the endogenous GM1 (Sonnino et al. 1989). On the contrary, the GM1 oligosaccharide is not 
taken up by the cells (Fig. 4S).  
Cells were UV illuminated and proteins analyzed for their tritium content, mirror of the stable 
cross linkage of the proteins with the photoactivated compound (Fig. 3). TrkA resulted cross 
linked to the GM1 oligosaccharide and to the GM1 carrying the photoactivated group on the 
position 6 of external galactose, but not with GM1 carrying the photoactivable group at the end 
of the acyl chain and located in the middle of membrane double layer. This result suggests that 
the distance between the GM1 ceramide moiety and the transmembrane portion of TrkA is too 
wide to establish the covalent linkage. This in agreement with the result indicating that TrkA is 
detergent soluble, while GM1 is not (Fig. 4).  
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It is reported that, at least keeping precise conditions, TrkA, that shows high dynamics within 
the membrane components, moves from fluid to rigid environments (Limpert et al. 2007; 
Ichikawa et al. 2009; Pryor et al. 2012). According to this, we should consider that the 
administration of GM1 to the cells, and its incorporation into the membrane rigid domain (Facci 
et al. 1984; Limpert et al. 2007; Ichikawa et al. 2009; Pryor et al. 2012), allows to reach a GM1 
membrane concentration high enough to block the dynamics of TrkA, forming then the TrkA-
GM1 complex through a TrkA-GM1 oligosaccharide interaction. Thus, when the TrkA 
approaches the boarder of the lipid rafts due to its dynamics in the fluid membrane, the 
extracellular environment of the soluble portion of TrkA, with an extension of the order of several 
tens of Å, may reach the GM1 oligosaccharide with no necessity for TrkA to belong to the same 
lipid membrane domain of GM1.  
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Online supplemental material.  
 
Figure 1S. This figure shows the scheme of the synthetic process for the preparation of [Gal-
6-3H]GM1(Cer-N3) 
 
Figure 2S. This figure shows the scheme of the synthetic process for the preparation of [Sph-
3-3H]GM1(Gal-N3) 
 
Figure 3S. This figure shows the scheme of the synthetic process for the preparation of [Gal-
6-3H]OligoGM1(Glc-N3). 
 
Figure 4S. This figure shows the association of GM1 oligosaccharide photoactivable derivative 
to N2a cells  
 
Figure 5S. This figure shows the N2a protein patterns 
 
Figure 6S. This figure shows the experiment time line diagrams.  
 
  
22 
 
Figure Legends 
 
Figure 1 – Chemical structure of GM1 photoactivable derivatives. A) [Gal-6-3H]GM1(Cer-
N3): tritiated GM1 derivative with a nitrophenylazide at the end of acyl chain; B) [Sph-3-
3H]GM1(Gal-N3)]: tritiated GM1 derivative with the nitrophenylazide at position 6 of external 
galactose; C) [Gal-6-3H]OligoGM1(Glc-N3): tritiated GM1 oligosaccharide derivative with the 
nitrophenylazide linked to the position 1 of glucose. 
 
Figure 2 – Time course of TrkA and ERK1/2 pathway activation followed by N2a 
differentiation. A-B) N2a cells were treated with 50 μM GM1 or OligoGM1 up to 12 h. The 
figure shows the expression of TrkA, phosphorylated TrkA (Tyr490), ERK1/2 and 
phosphorylated ERK1/2 in cell lysate by means of specific antibodies and reveled by enhanced 
chemiluminescence. Top: immunoblotting images are shown. Bottom: Semi-quantitative 
analysis of phosphorylated TrkA (A) and ERK1/2 (B) related to total level of TrkA and ERK1/2, 
respectively. Data are expressed as fold increase over control of the mean ± SEM from three 
independent cell culture preparations (*p < 0.05, Mann Whitney test, n=3). C) Morphological 
analysis of N2a cells. 1, control; 2, OligoGM1. Following 24 h incubation, cells were analyzed 
by contrast phase microscopy with 200x magnification. Images are representative of ten 
independent cell culture preparations (n=10) [white square: control, light gray square: GM1; 
dark gray square: OligoGM1]. 
 
Figure 3 – Interaction between TrkA and GM1 in N2a cells. Photoactivable derivatives of 
GM1 were administered to N2a cells and cells were then illuminated. Proteins of cell lysate 
were submitted to 4-10% acrylamide SDS-PAGE, transferred on PVDF membrane and 
visualized by digital autoradiography for 96 h (right). The same PVDF was blotted using specific 
antibody anti TrkA (left). The images are representative of three independent cell culture 
preparations. A) Interaction between TrkA and [Gal-6-3H]GM1(Cer-N3)M; B) Interaction 
between TrkA and [Sph-3-3H]GM1(Gal-N3)]; C) Interaction between TrkA and [Gal-6-
3H]OligoGM1(Glc-N3); B) Glycoconjugates representation is according to Varki et al. 2015 
(green star: photoactivable group). 
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Figure 4 – Sucrose gradient fractions characterization. N2a cells were incubated in the 
absence (A, control), or in the presence of 50 μM GM1 (B) or 50 μM OligoGM1 (C) for 3 h at 
37°C. Cells were subsequently subjected to sucrose gradient ultracentrifugation to prepare 
plasma membrane microdomains. Twelve fractions were collected from the top of the tube, with 
fractions 4-6 corresponding to the detergent resistant membrane (DRM) fractions and fractions 
10-12 corresponding to high density (HD) fractions. Left: Immunoblotting against the TrkA, 
calnexin (HD marker) and flotillin (DRM marker) performed on postnuclear supernatant (PNS) 
and on the 12 fractions. Images are representative of three independent cell culture 
preparations.. Right: GM1 detection among total lipids extracted from each sucrose fraction, 
revealed by cholera toxin subunit B (CT-B) TLC-staining (std: GM1 standard). 
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